Human IL-23 antigen binding proteins

US9487580B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9487580-B2
Application numberUS-201414228556-A
CountryUS
Kind codeB2
Filing dateMar 28, 2014
Priority dateOct 26, 2009
Publication dateNov 8, 2016
Grant dateNov 8, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Antigen binding proteins that bind to human IL-23 protein are provided. Nucleic acids encoding the antigen binding protein, vectors, and cells encoding the same as well as use of IL-23 antigen binding proteins for diagnostic and therapeutic purposes are also provided.

First claim

Opening claim text (preview).

What is claimed is: 1. An isolated antigen binding protein that binds IL-23, comprising: a CDRH1 of SEQ ID NO: 109; a CDRH2 of SEQ ID NO: 116; a CDRH3 of SEQ ID NO: 111; a CDRL1 of SEQ ID NO: 80; a CDRL2 of SEQ ID NO: 81; and a CDRL3 of SEQ ID NO: 76. 2. An isolated antigen binding protein that binds IL-23 comprising: a heavy chain variable region comprising amino acid residues 31-37, 52-67 and 100-109 of SEQ ID NO: 46 or 153; and a light chain var…

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Next steps

Free tools are coming soon. Tell us what you want to track and we'll notify you.

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9487580B2 cover?
Antigen binding proteins that bind to human IL-23 protein are provided. Nucleic acids encoding the antigen binding protein, vectors, and cells encoding the same as well as use of IL-23 antigen binding proteins for diagnostic and therapeutic purposes are also provided.
Who is the assignee on this patent?
Towne Jennifer E, Cheng Janet D, O'Neill Jason C, and 6 more
What technology area does this patent fall under?
Primary CPC classification C07K16/244. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).